Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Anxiety During Pregnancy in the Era of the COVID-19 Pandemic
18 Pages Posted: 18 May 2020More...
Background: To assess anxiety symptoms in pregnant women living in the quarantine conditions in Greece, due to the COVID-19 pandemic.
Methods: All pregnant women that received routine antenatal care in a university clinic following total lockdown in Greece were eligible to participate in the study. The Greek version of the State-Trait Anxiety Inventory (Form Y) was employed. Associated risk factors for maternal anxiety were also investigated.
Results: In total, 146 women consented to participate in the survey. Αnxiety in pregnancy was estimated to affect 53.4% of the participants (S-Anxiety) whereas lifetime anxiety (T-Anxiety) was reported in 34.2% of the women (p<0.001). Moreover, the median S-Anxiety score was higher than the median T-Anxiety value [40 (range 21-67) versus 34 (range 23-67) respectively; p<0.001], thus indicating a significant increase in anxiety levels during the lockdown. For S-anxiety, 28.1% of the women were classified as non-anxious (score<35), 35.6% with mild anxiety (score 35-45), 20.5% with moderate anxiety (score 46-55), 12.3% with high anxiety (score 56-65) and 3.4% with very high anxiety (score > 65). The number of weeks after lockdown (first week - OR: 6.924; 95% CI: 2.807-17.027, second week - OR: 2.654; 95% CI: 1.138-6.192, third week – OR: 1.000) and smoking (OR: 3.815; 95% CI: 1.215-11.985) in pregnancy were identified as independent risk factors for anxiety. No differences were found in the incidence of anxiety between the three trimesters of pregnancy.
Conclusion: A significant increase in anxiety levels during the lockdown was observed in pregnant women, with the increase being highest in the first week of the quarantine, gradually regressing in the second and reaching almost normal levels in the third week. This finding may be associated with the effective mitigation measures on the spread of the disease in Greece.
Funding Statement: None.
Declaration of Interests: None to declare.
Ethics Approval Statement: The research complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration. Moreover, the study protocol was approved by the bioethics committee of the Aristotle University of Thessaloniki and a written informed consent was necessary in order to participate.
Keywords: anxiety, pregnancy, covid-19, pandemic, stai questionnaire
Suggested Citation: Suggested Citation